JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nebeling, L. C.
Right arrow Articles by Lerner, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nebeling, L. C.
Right arrow Articles by Lerner, E.

Journal of the American College of Nutrition, Vol 14, Issue 2 202-208, Copyright © 1995 by American College of Nutrition


JOURNAL ARTICLE

Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports

L. C. Nebeling, F. Miraldi, S. B. Shurin and E. Lerner
Nutrition Department, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.

OBJECTIVE: Establish dietary-induced ketosis in pediatric oncology patients to determine if a ketogenic state would decrease glucose availability to certain tumors, thereby potentially impairing tumor metabolism without adversely affecting the patient's overall nutritional status. DESIGN: Case report. SETTING: University Hospitals of Cleveland. SUBJECTS: Two female pediatric patients with advanced stage malignant Astrocytoma tumors. INTERVENTIONS: Patients were followed as outpatients for 8 weeks. Ketosis was maintained by consuming a 60% medium chain triglyceride oil-based diet. MAIN OUTCOME MEASURES: Tumor glucose metabolism was assessed by Positron Emission Tomography (PET), comparing [Fluorine-18] 2-deoxy-2-fluoro-D-glucose (FDG) uptake at the tumor site before and following the trial period. RESULTS: Within 7 days of initiating the ketogenic diet, blood glucose levels declined to low-normal levels and blood ketones were elevated twenty to thirty fold. Results of PET scans indicated a 21.8% average decrease in glucose uptake at the tumor site in both subjects. One patient exhibited significant clinical improvements in mood and new skill development during the study. She continued the ketogenic diet for an additional twelve months, remaining free of disease progression. CONCLUSION: While this diet does not replace conventional antineoplastic treatments, these preliminary results suggest a potential for clinical application which merits further research.


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. A. Kiebish, X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried
Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer
J. Lipid Res., December 1, 2008; 49(12): 2545 - 2556.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Marsh, P. Mukherjee, and T. N. Seyfried
Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma
Clin. Cancer Res., December 1, 2008; 14(23): 7751 - 7762.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. M. Freeman, E. H. Kossoff, and A. L. Hartman
The Ketogenic Diet: One Decade Later
Pediatrics, March 1, 2007; 119(3): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. Evangeliou, I. Vlachonikolis, H. Mihailidou, M. Spilioti, A. Skarpalezou, N. Makaronas, A. Prokopiou, P. Christodoulou, G. Liapi-Adamidou, E. Helidonis, et al.
Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study
J Child Neurol, February 1, 2003; 18(2): 113 - 118.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Nutrition.